Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach
Author(s) -
Raghavan Chinnadurai,
Devi Rajan,
Muna Qayed,
Dalia Arafat,
Marco Garcia,
Yifei Liu,
Subra Kugathasan,
Larry J. Anderson,
Greg Gibson,
Jacques Galipeau
Publication year - 2018
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2018.02.013
Subject(s) - potency , mesenchymal stem cell , immune system , peripheral blood mononuclear cell , cytokine , homing (biology) , biology , immunology , computational biology , microbiology and biotechnology , in vitro , biochemistry , ecology
Assays that can characterize MSC immune potency need to be identified for use in advanced clinical trials. MSCs possess a number of putative regenerative and immunomodulatory properties, and an assay matrix approach may best capture involved effector pathways. We have tested two assay systems to measure the potency of MSCs derived from human subjects: MSC secretome analysis and a quantitative RNA-based array for genes specific to immunomodulatory and homing properties of MSCs. Secretome analysis identified a unique cytokine signature that is upregulated by MSCs or downregulated in responder PBMCs and correlated with T cell suppression. Use of interferon-γ as a surrogate for the action of activated PBMCs on MSCs served as an alternative for the use of human PBMCs as responder cells in a potency assay. Our approach and results define and simplify the multifunctional or matrix responses of MSCs and may serve as a platform for robust potency analysis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom